Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Genome-wide meta-analysis of homocysteine and methionine metabolism identifies five one carbon metabolism loci and a novel association of ALDH1L1 with ischemic stroke.

Williams SR, Yang Q, Chen F, Liu X, Keene KL, Jacques P, Chen WM, Weinstein G, Hsu FC, Beiser A, Wang L, Bookman E, Doheny KF, Wolf PA, Zilka M, Selhub J, Nelson S, Gogarten SM, Worrall BB, Seshadri S, Sale MM; Genomics and Randomized Trials Network; Framingham Heart Study.

PLoS Genet. 2014 Mar 20;10(3):e1004214. doi: 10.1371/journal.pgen.1004214. eCollection 2014 Mar.

2.

Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial.

Pettigrew LC, Bang H, Chambless LE, Howard VJ, Toole JF; Vitamin Intervention for Stroke Prevention Investigators.

Atherosclerosis. 2008 Oct;200(2):345-9. doi: 10.1016/j.atherosclerosis.2007.11.014. Epub 2007 Dec 31.

3.

Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.

de Jong SC, Stehouwer CD, van den Berg M, Kostense PJ, Alders D, Jakobs C, Pals G, Rauwerda JA.

Arterioscler Thromb Vasc Biol. 1999 May;19(5):1316-24.

4.

Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway.

Hazra A, Kraft P, Lazarus R, Chen C, Chanock SJ, Jacques P, Selhub J, Hunter DJ.

Hum Mol Genet. 2009 Dec 1;18(23):4677-87. doi: 10.1093/hmg/ddp428. Epub 2009 Sep 10.

5.

Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: the impact of age in the VISP trial.

Towfighi A, Arshi B, Markovic D, Ovbiagele B.

Cerebrovasc Dis. 2014;37(4):263-7. doi: 10.1159/000360153. Epub 2014 Apr 15.

PMID:
24751920
6.

Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.

Ho GY, Eikelboom JW, Hankey GJ, Wong CR, Tan SL, Chan JB, Chen CP.

Stroke. 2006 Feb;37(2):456-60. Epub 2006 Jan 5.

7.

Modeling cellular compartmentation in one-carbon metabolism.

Scotti M, Stella L, Shearer EJ, Stover PJ.

Wiley Interdiscip Rev Syst Biol Med. 2013 May-Jun;5(3):343-65. doi: 10.1002/wsbm.1209. Epub 2013 Feb 13. Review.

8.

Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study.

Cheng TY, Makar KW, Neuhouser ML, Miller JW, Song X, Brown EC, Beresford SA, Zheng Y, Poole EM, Galbraith RL, Duggan DJ, Habermann N, Bailey LB, Maneval DR, Caudill MA, Toriola AT, Green R, Ulrich CM.

Cancer. 2015 Oct 15;121(20):3684-91. doi: 10.1002/cncr.29465. Epub 2015 Jun 24.

9.

Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke.

Kristensen B, Malm J, Nilsson TK, Hultdin J, Carlberg B, Dahlén G, Olsson T.

Stroke. 1999 May;30(5):974-80.

10.

Post-methionine-load hyperhomocysteinemia and increased lipoprotein(a) are associated with renal metabolic dysfunction: a hypothesis.

Herrmann W, Stanger O, Knapp JP, Semmelrock HJ, Lemmerer M, Rigler B.

Metabolism. 2002 Oct;51(10):1235-40.

PMID:
12370840
11.

Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency.

Lu YH, Cheng LM, Huang YH, Lo MY, Wu TJ, Lin HY, Hsu TR, Niu DM.

Clin Nutr. 2015 Dec;34(6):1155-8. doi: 10.1016/j.clnu.2014.11.013. Epub 2014 Dec 3.

PMID:
25516282
12.

Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease.

van Meurs JB, Pare G, Schwartz SM, Hazra A, Tanaka T, Vermeulen SH, Cotlarciuc I, Yuan X, Mälarstig A, Bandinelli S, Bis JC, Blom H, Brown MJ, Chen C, Chen YD, Clarke RJ, Dehghan A, Erdmann J, Ferrucci L, Hamsten A, Hofman A, Hunter DJ, Goel A, Johnson AD, Kathiresan S, Kampman E, Kiel DP, Kiemeney LA, Chambers JC, Kraft P, Lindemans J, McKnight B, Nelson CP, O'Donnell CJ, Psaty BM, Ridker PM, Rivadeneira F, Rose LM, Seedorf U, Siscovick DS, Schunkert H, Selhub J, Ueland PM, Vollenweider P, Waeber G, Waterworth DM, Watkins H, Witteman JC, den Heijer M, Jacques P, Uitterlinden AG, Kooner JS, Rader DJ, Reilly MP, Mooser V, Chasman DI, Samani NJ, Ahmadi KR.

Am J Clin Nutr. 2013 Sep;98(3):668-76. doi: 10.3945/ajcn.112.044545. Epub 2013 Jul 3.

13.

Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.

Ventura P, Panini R, Emiliani S, Salvioli G.

Exp Clin Endocrinol Diabetes. 2004 Jan;112(1):44-51.

PMID:
14758571
14.

Association of a 31 bp VNTR in the CBS gene with postload homocysteine concentrations in the Framingham Offspring Study.

Lievers KJ, Kluijtmans LA, Blom HJ, Wilson PW, Selhub J, Ordovas JM.

Eur J Hum Genet. 2006 Oct;14(10):1125-9. Epub 2006 Jun 21.

15.

Genetic evidence that nitric oxide modulates homocysteine: the NOS3 894TT genotype is a risk factor for hyperhomocystenemia.

Brown KS, Kluijtmans LA, Young IS, Woodside J, Yarnell JW, McMaster D, Murray L, Evans AE, Boreham CA, McNulty H, Strain JJ, Mitchell LE, Whitehead AS.

Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):1014-20. Epub 2003 Apr 10.

16.

Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial.

Viswanathan A, Raj S, Greenberg SM, Stampfer M, Campbell S, Hyman BT, Irizarry MC.

Neurology. 2009 Jan 20;72(3):268-72. doi: 10.1212/01.wnl.0000339486.63862.db.

17.

Betaine: a key modulator of one-carbon metabolism and homocysteine status.

Ueland PM, Holm PI, Hustad S.

Clin Chem Lab Med. 2005;43(10):1069-75. Review.

PMID:
16197300
18.

Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial.

Keene KL, Chen WM, Chen F, Williams SR, Elkhatib SD, Hsu FC, Mychaleckyj JC, Doheny KF, Pugh EW, Ling H, Laurie CC, Gogarten SM, Madden EB, Worrall BB, Sale MM.

Front Public Health. 2014 Aug 6;2:112. doi: 10.3389/fpubh.2014.00112. eCollection 2014.

19.

Association between the 2756A> G variant in the gene encoding methionine synthase and myocardial infarction in Tunisian patients.

Jemaa R, Achouri A, Kallel A, Ben Ali S, Mourali S, Feki M, Elasmi M, Taieb SH, Sanhaji H, Omar S, Mechmeche R, Kaabachi N.

Clin Chem Lab Med. 2008;46(10):1364-8. doi: 10.1515/CCLM.2008.306.

PMID:
18844488
20.

The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations.

Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, Evans A, Whitehead AS.

Atherosclerosis. 2001 Aug;157(2):451-6.

PMID:
11472746

Supplemental Content

Support Center